Table 2.
Mutagenic activity for aqueous extract of C. nervosum based on non-metabolic (–S9) and metabolic activation (+S9) using S. typhimurium TA 98 and TA100 strain.
Treatment | Average of His+ revertant colonies | |||
---|---|---|---|---|
TA 98 | TA100 | |||
– S9 | + S9 | – S9 | + S9 | |
AF-2 2 ug/ml | 286±32.6 | N.A. | 834±184.3 | N.A. |
2-AA 10 ug/ml | N.A. | 408±35.9 | N.A. | 612±186.9 |
DW 50 ul | 32±6.3 | 37±9.4 | 143±34.8 | 180±36.7 |
C. nervosum extract 0.8 mg/ml | 32±6.1 | 26±3.7 | 138±39.2 | 134±36.1 |
C. nervosum extract 4 mg/ml | 32±9.0 | 24±3.7 | 137±41.7 | 135±38.0 |
C. nervosum extract 20 mg/ml | 32±8.8 | 22±4.8 | 133±31.4 | 139±36.6 |
C. nervosum extract 100 mg/ml | 31±8.0 | 24±1.7 | 141±44.2 | 129±32.2 |
C. nervosum extract 200 mg/ml | 37±15 | 30±9.1 | N.A. | N.A. |
The His+ revertant colonies are expressed as Mean±SEM of three independent replicates.
AF-2; 2-(2-furyl)-3-(5-nitro-2-furyl)-acrylamide, 2-AA; 2-aminoanthracene, DW; distilled water, N.A.; not analyzed